Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment
Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment
Recruiting · NCT07651878 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-06-16 | NCT07651878 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clinfidence B.V. | 1 |
| Mendus | 1 |
| TFS HealthScience | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Haukeland University Hospital | Bergen | Norway | 52 |